We are studying early-treated HIV-1 patients who stopped their antiretroviral therapy to find out if specific genetic and immune markers can predict their ability to control the virus. This research may help improve future treatment strategies.
Health conditions and diseases that the clinical trial is designed to study and treat.
HIV-1 positive subjects treated with effective antiretroviral therapy during the acute phase of HIV-1 infection are individuals who have recently contracted the virus and are receiving treatment to manage their condition. This early intervention is crucial for controlling the virus and preventing progression to AIDS.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.